> top > docs > PMC:2674207 > spans > 1804-2107 > annotations

PMC:2674207 / 1804-2107 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T375 0-11 NN denotes Conclusions
T376 12-27 NN denotes Corticosteroids
T377 28-32 VB denotes have
T378 33-34 DT denotes a
T379 35-41 JJ denotes potent
T380 42-52 JJ denotes inhibitory
T381 53-59 NN denotes effect
T382 60-62 IN denotes on
T383 63-69 NN denotes GATA-3
T384 70-73 IN denotes via
T385 74-77 CD denotes two
T386 78-89 VB denotes interacting
T387 90-100 NN denotes mechanisms
T388 101-105 WDT denotes that
T389 106-114 RB denotes potently
T390 115-123 VB denotes suppress
T391 124-127 NN denotes Th2
T392 128-136 NN denotes cytokine
T393 137-147 NN denotes expression
T394 149-153 DT denotes This
T395 154-159 JJ denotes novel
T396 160-169 NN denotes mechanism
T397 170-172 IN denotes of
T398 173-179 NN denotes action
T399 180-182 IN denotes of
T400 183-198 NN denotes corticosteroids
T401 199-202 MD denotes may
T402 203-210 VB denotes account
T403 211-214 IN denotes for
T404 215-218 DT denotes the
T405 219-227 JJ denotes striking
T406 228-236 JJ denotes clinical
T407 237-245 NN denotes efficacy
T408 246-248 IN denotes of
T409 249-264 NN denotes corticosteroids
T410 265-267 IN denotes in
T411 268-271 DT denotes the
T412 272-281 NN denotes treatment
T413 282-284 IN denotes of
T414 285-293 JJ denotes allergic
T415 294-302 NN denotes diseases
R283 T376 T377 arg1Of Corticosteroids,have
R284 T377 T384 arg1Of have,via
R286 T380 T379 arg1Of inhibitory,potent
R287 T381 T377 arg2Of effect,have
R288 T381 T378 arg1Of effect,a
R289 T381 T380 arg1Of effect,inhibitory
R291 T381 T382 arg1Of effect,on
R292 T383 T382 arg2Of GATA-3,on
R295 T387 T384 arg2Of mechanisms,via
R296 T387 T385 arg1Of mechanisms,two
R297 T387 T386 arg1Of mechanisms,interacting
R298 T387 T388 arg1Of mechanisms,that
R299 T387 T390 arg1Of mechanisms,suppress
R300 T390 T389 arg1Of suppress,potently
R304 T393 T390 arg2Of expression,suppress
R305 T393 T391 arg1Of expression,Th2
R306 T393 T392 arg1Of expression,cytokine
R307 T396 T394 arg1Of mechanism,This
R308 T396 T395 arg1Of mechanism,novel
R309 T396 T397 arg1Of mechanism,of
R310 T396 T401 arg1Of mechanism,may
R311 T396 T402 arg1Of mechanism,account
R312 T398 T397 arg2Of action,of
R313 T398 T399 arg1Of action,of
R314 T400 T399 arg2Of corticosteroids,of
R315 T402 T401 arg2Of account,may
R316 T402 T403 arg1Of account,for
R320 T407 T403 arg2Of efficacy,for
R321 T407 T404 arg1Of efficacy,the
R322 T407 T405 arg1Of efficacy,striking
R323 T407 T406 arg1Of efficacy,clinical
R324 T407 T408 arg1Of efficacy,of
R325 T407 T410 arg1Of efficacy,in
R326 T409 T408 arg2Of corticosteroids,of
R328 T412 T410 arg2Of treatment,in
R329 T412 T411 arg1Of treatment,the
R330 T412 T413 arg1Of treatment,of
R332 T415 T413 arg2Of diseases,of
R333 T415 T414 arg1Of diseases,allergic

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T687 0-11 NNS denotes Conclusions
T688 12-27 NNS denotes Corticosteroids
T689 28-32 VBP denotes have
T690 33-34 DT denotes a
T691 35-41 JJ denotes potent
T692 42-52 JJ denotes inhibitory
T693 53-59 NN denotes effect
T694 60-62 IN denotes on
T695 63-69 JJ denotes GATA-3
T696 70-73 IN denotes via
T697 74-77 CD denotes two
T698 78-89 VBG denotes interacting
T699 90-100 NNS denotes mechanisms
T700 101-105 WDT denotes that
T701 106-114 RB denotes potently
T702 115-123 VBP denotes suppress
T703 124-127 JJ denotes Th2
T704 128-136 NN denotes cytokine
T705 137-147 NN denotes expression
T706 147-148 . denotes .
T707 149-153 DT denotes This
T708 154-159 NN denotes novel
T709 160-169 NN denotes mechanism
T710 170-172 IN denotes of
T711 173-179 NN denotes action
T712 180-182 IN denotes of
T713 183-198 NNS denotes corticosteroids
T714 199-202 MD denotes may
T715 203-210 VB denotes account
T716 211-214 IN denotes for
T717 215-218 DT denotes the
T718 219-227 JJ denotes striking
T719 228-236 JJ denotes clinical
T720 237-245 NN denotes efficacy
T721 246-248 IN denotes of
T722 249-264 NNS denotes corticosteroids
T723 265-267 IN denotes in
T724 268-271 DT denotes the
T725 272-281 NN denotes treatment
T726 282-284 IN denotes of
T727 285-293 JJ denotes allergic
T728 294-302 NNS denotes diseases
T729 302-303 . denotes .
R604 T717 T720 det the,efficacy
R612 T718 T720 amod striking,efficacy
R614 T719 T720 amod clinical,efficacy
R615 T720 T716 pobj efficacy,for
R617 T721 T720 prep of,efficacy
R618 T722 T721 pobj corticosteroids,of
R620 T723 T722 prep in,corticosteroids
R621 T724 T725 det the,treatment
R622 T725 T723 pobj treatment,in
R624 T726 T725 prep of,treatment
R625 T727 T728 amod allergic,diseases
R559 T687 T688 compound Conclusions,Corticosteroids
R560 T688 T689 nsubj Corticosteroids,have
R561 T689 T689 ROOT have,have
R563 T690 T693 det a,effect
R564 T691 T693 amod potent,effect
R566 T692 T693 amod inhibitory,effect
R567 T693 T689 dobj effect,have
R568 T694 T693 prep on,effect
R570 T695 T694 pobj GATA-3,on
R571 T696 T689 prep via,have
R576 T697 T699 nummod two,mechanisms
R578 T698 T699 amod interacting,mechanisms
R579 T699 T696 pobj mechanisms,via
R580 T700 T702 nsubj that,suppress
R582 T701 T702 advmod potently,suppress
R583 T702 T699 relcl suppress,mechanisms
R585 T703 T705 amod Th2,expression
R586 T704 T705 amod cytokine,expression
R587 T705 T702 dobj expression,suppress
R589 T706 T689 punct .,have
R590 T707 T709 det This,mechanism
R591 T708 T709 amod novel,mechanism
R593 T709 T715 nsubj mechanism,account
R594 T710 T709 prep of,mechanism
R595 T711 T710 pobj action,of
R597 T712 T711 prep of,action
R598 T713 T712 pobj corticosteroids,of
R599 T714 T715 aux may,account
R601 T715 T715 ROOT account,account
R602 T716 T715 prep for,account
R626 T728 T726 pobj diseases,of
R627 T729 T715 punct .,account

sentences

Id Subject Object Predicate Lexical cue
T145 0-11 Sentence denotes Conclusions
T146 12-148 Sentence denotes Corticosteroids have a potent inhibitory effect on GATA-3 via two interacting mechanisms that potently suppress Th2 cytokine expression.
T147 149-303 Sentence denotes This novel mechanism of action of corticosteroids may account for the striking clinical efficacy of corticosteroids in the treatment of allergic diseases.
T15 0-11 Sentence denotes Conclusions
T16 12-148 Sentence denotes Corticosteroids have a potent inhibitory effect on GATA-3 via two interacting mechanisms that potently suppress Th2 cytokine expression.
T17 149-303 Sentence denotes This novel mechanism of action of corticosteroids may account for the striking clinical efficacy of corticosteroids in the treatment of allergic diseases.

events-check-again

Id Subject Object Predicate Lexical cue
T917 42-59 Negative_regulation denotes inhibitory effect
T918 63-69 Protein denotes GATA-3
R727 T918 T917 themeOf GATA-3,inhibitory effect

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T952 63-69 Protein denotes GATA-3
T953 124-127 Protein denotes Th2
T954 53-59 Negative_regulation denotes effect
T955 137-147 Gene_expression denotes expression
T956 115-123 Negative_regulation denotes suppress
R764 T952 T954 themeOf GATA-3,effect
R765 T953 T955 themeOf Th2,expression
R767 T955 T956 themeOf expression,suppress

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue
T133 42-59 Negative_regulation denotes inhibitory effect
T134 63-69 Protein denotes GATA-3
R98 T134 T133 themeOf GATA-3,inhibitory effect

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T453 63-69 P23771 denotes GATA-3

test2

Id Subject Object Predicate Lexical cue
T85 42-59 Negative_regulation denotes inhibitory effect
T86 63-69 Protein denotes GATA-3
R70 T86 T85 themeOf GATA-3,inhibitory effect